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1. Introduction
The function of the gut microbiome and the bidirectional communication between the
gastrointestinal tract (GIT) and the brain is increasingly recognized in health and disease and
disruption in its composition is not unique to the autistic pathology. However, the bidirectional
communication between the gut and the brain, “the gut-brain/brain-gut axis” in autism has
been relatively understudied. In general, this communication between gut and brain occurs
through a direct neuronal pathway via the vagus nerve, the hormonal pathway of several
hormones involved in the regulation of food intake, such as cholecystokinin (CCK), ghrelin,
leptin and insulin, and by the immunological signaling pathway involving cytokines. Recent
studies indicate that the vagus nerve is involved in immunomodulation as suggested by its
ability to attenuate the production of proinflammatory cytokines in experimental models of
inflammation (de Jonge and Ullola, 2007). Furthermore, the gut microbiome emerges as a major
player not only in the maturation of GIT tissue and the gut brain axis but also in brain
maturation, through its effect on both the immune and endocrine systems. Many toxins,
toxicants, infectious agents, diet or stress, affect an individual’s gut microbiome, which may
be especially sensitive during the critical developmental period. Disruption of the developing
microbiome may have profound consequences on the developing gut-brain axis including the
brain as well as long-term effects on both the physical and psychological development.
This chapter attempts to bridge basic animal studies with clinical findings pertaining to the
brain-gut and gut microbiome in autism, and includes a discussion of various strategies in
managing autistic symptoms. The discussion also includes possible changes in the reward
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system(s) in autism as a consequence of altered gut microbiome. It is possible that aberrant
regulation of the reward system(s) underlines behavioral abnormalities in ASD that could be
targeted by future microbiome-targeting therapies.
2. Effect of perinatal infection and toxicants on the developing brain
In a continuing quest to understand the nature of gene-environment interactions in ASD, we
have recently completed two animal studies examining the effect of perinatal exposure of
thimerosal (TM) and lipopolysaccharides (LPS) on the developing rat central nervous system
(CNS). Both TM and infections (modeled by LPS exposure) have been implicated in autistic
pathology.
Organic mercury compounds are powerful toxicants with a range of harmful neurological
effects in humans and animals. TM, which is metabolized to ethyl mercury, has been discon‐
tinued as a preservative from infant vaccines but continues to be used in several vaccines
including a flu vaccine administered to pregnant and lactating mothers (Sulkowski et al.,
2012). Perinatal maternal exposure of two strains of rats, Sprague Dawley (SD) and spontane‐
ously hypertensive (SHR) rats, to thimerosal (200 ug/kg body weight) resulted in both sex- and
strain-specific abnormalities in the neonatal rats (Sulkowski et al., 2012). Behavioral abnor‐
malities included delayed startle response and decreased motor learning, with the effects being
both sex- and strain-specific. TM exposure also resulted in a significant increase in cerebellar
levels of an oxidative stress marker (3-nitrotyrosine) and a decrease in cerebellar type 2
deiodinase, responsible for local intrabrain conversion of thyroxine to the active hormone, 3’,
3,5,-triiodothyronine (T3). These effects were associated with an increased expression of
several genes negatively regulated by T3 (Sulkowski et al., 2012); Khan et al., 2012) suggesting
that perinatal exposure to TM impacts the developing brain at the genetic level. As TM
exposure during the postnatal phase coincided with lactation, some of the TM was delivered
through the milk to the GIT and may have had an effect on the developing gut microbiome
known to be sensitive to heavy metal exposure (Lapanje et al., 2007). This effect may be in part
due to competition with zinc resulting in a disturbance in metallothionein function and general
chelating capacity for other metals. Thus, at least part of the neonatal impact of TM/mercury
could be mediated via its action on the gut microbiome.
In a related study (Xu et al., submitted) we examined the effect of E.coli lipopolysaccharides
(LPS) exposure during critical developmental periods on the developing brain employing the
animal model of infection. Clinical and epidemiological data suggest that maternal infection
during pregnancy and nursing increases the probability of neonatal brain injury and may have
a long-lasting impact on brain functions. Maternal infection during pregnancy has been linked
to neurological and neurobehavioral disorders in humans such as cerebral palsy (Schendel,
2001; Schendel et al., 2002), neonatal strokes (Ferrieo, 2004), schizophrenia (Watson et al.,
1999; Pearce, 2001) and affective disorders (Watson et al., 1999). Animal studies implicate
bacterial infection in the pathology of Parkinson’s disease (Carvey et al., 2003), and notably,
schizophrenia and autism (Patterson, 2002). The triggering signals for cytokine production are
endotoxins, major components of the outer membrane of Gram-negative bacteria.
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LPS exposure is one of the most acceptable models of infection; LPS is a sufficient trigger for
cytokine production. LPS administered to the pregnant mother are transferred to the fetus
through the placenta (Kohmura et al., 2000), and result in increased cytokines levels in the
amniotic fluid (Urakabo et al., 2001; Gayle et al., 2004) and the fetal brain (Urakabo et al., 2001).
Bacterial infection of lactating mothers also results in an increased level of cytokines in milk
(Bannerman et al., 2004). Pretreatment of suckling rats with LPS (10 mg/kg-day x 5 days – the
dose which produces weak, transient signs of endotoxemia) results in reduced pancreatic
secretion and attenuates acute pancreatitis at adult age due to an increased concentration of
the antioxidative enzyme SO in the pancreatic tissue, and to the modulation of cytokines
production (Jaworek at al., 2007a, b). This late-effect of LPS is accompanied by dose-dependent
reduction of mRNA signal for CCK1 receptor on pancreatic acini as well as modified expres‐
sion of acinar pro-apoptotic heat shock protein-60 (HSP60) and Bax proteins (Jaworek et al.,
2007b, 2008). Early postnatal LPS exposure results in inceased expression of toll-like receptor
4 (TLR4) and caspase-3 and 9- proteins in the pancreatic tissue of adult rats (Bonior et al.,
2012). These studies clearly indicate that perinatal exposure to LPS may have long lasting
consequences on the GIT function, and as expected, though not studied in detail, on the brain-
gut axis.
Perinatal maternal exposure of two strains of rats, SHR or SD rat dams to LPS (200 µg/kg body
weight) resulted in increased rollover time, delayed startle, and decreased motor learning,
with the effects being both strain- and sex-specific. LPS challenge also resulted in a trend
towards an increase in cerebellar levels of 3-NT and a decrease in D2 activities in LPS-exposed
pups (Xu et al., submitted). Several genes were affected by LPS. Notably Type 2 deiodinase 2
(DIO2) and brain derived neurotrophic factor (BDNF) expression was significantly elevated,
while transthyretin (TTR) expression was decreased following LPS exposure. In vitro, acute
exposure of cerebellar cultures to LPS resulted in a decreased size of the dendritic area of
Purkinje cells. Our data thus demonstrate that perinatal infection impacts the developing
cerebellum in a sex- and strain-dependent manner via mechanisms involving oxidative stress,
enzymes involved in maintaining local TH homeostasis, and downstream gene expression.
Interestingly, gene changes observed in the brains of LPS-exposed rats were distinct from TM-
associated gene effect suggesting that the underlying macromolecular mechanism may be
trigger-specific.
Perinatal LPS exposure could have a profound effect on the gut microbiome similar to the
effect of repeated treatment with antibiotics. Experiments in healthy mice have shown that
disrupting the normal balance of the gut microbiome with antibiotics caused changes in mice
behavior and was accompanied by changes in BDNF which has been linked to depression and
anxiety (Bercik et al., 2011; Neufeld et al., 2011). Perinatal LPS exposure most likely affects gut
motility as suggested by studies of irritable bowel syndrome (IBS), where mild bacterial
overgrowth-associated motility disorder can be reversed by antimicrobials (Scarpignato and
Pelosini, 1999). Animal studies have also shown that stress can change the composition of the
microbiome, where the changes are associated with increased vulnerability to inflammatory
stimuli in the GIT. Could gut dysbiosis be induced by recurrent infections? We have observed
an increase in neurotrophin levels in the cerebella of rats exposed to LPS (Sajdel-Sulkowska et
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al, unpublished observation) and brain region-specific changes in neurotrophin levels in ASD
(Sajdel-Sulkowska et al., 2011). Together these observations suggest that a bacterial infection
could trigger the gut microbiome to induce cytokine overproduction leading to an imbalance
of brain neurotrophins and contribute to developmental abnormalities.
3. Effect of environmental perturbations on the developing components of
the brain-gut axis: Intestinal permeability, inflammation and gut
microbiome
As indicated above the perinatal development of the CNS structure and function greatly
depends on the gastrointestinal GIT function. Little is known about the regulation of embry‐
onic gut epithelium or the effect of prenatal infection. The two key developmental time-points
in the regulation of the GIT both occur postnatally, the first few days after birth when all gut
digestive functions are launched by first colostrum ingestion and the second at weaning when
the digestive system has to modify its function following a switch from mother’s milk to solid
food. The first time-point is particularly relevant for all mammalian species since it is associated
with a complex of dynamic changes in the GIT structure and function leading to a temporary
drop in the gut permeability barrier. The secretion of digestive juices (e.g., gastric and
pancreatic juice secretion) is obviously close to null before birth. Our studies indicate that in
neonatal calves the exocrine pancreas secreted low but measurable amounts of pancreatic juice
from the first postnatal day. The secretion responded to colostrum feeding showing a clear-
cut cephalic phase associated with plasma pancreatic polypeptide (PP) elevation but no gastric
or intestinal phase. Further studies involving vagal blockades and pharmacological cholecys‐
tokinin receptor antagonists indicated that in neonatal calves pancreatic response to first
colostrum feeding is already controlled by a neuro-hormonal mechanism involving CCK and
long vago-vagal reflex (Zabielski et al., 2002). Thus, the brain-gut axis control of the exocrine
pancreas observed in one- and two-month old milk-fed calves is already present at birth, only
the magnitude of the response increases with age reaching its peak at four weeks. The other
GIT function in neonatal calves closely associated with the brain-gut axis control include
periodic activity of GIT motility (migrating motor complex, MMC) and secretion (pancreatic
juice periodic secretion) observed already two-three days after birth along with plasma PP
oscillations (Zabielski et al., 2002). Plasma PP, a marker of efferent vagal activity, increased
with age indicating that brain-gut axis further develops after birth (and may be potentially
sensitive to any environmental modifications).
Intestinal  functions  in  neonates  are  far  more  complex  than  in  adults  due  to  intensive
developmental processes. The small intestine is one of the fastest body organs to grow in
size postnatally as well as the fastest organ in rebuilding its structure. Relatively little is
known regarding the development of the large intestine, a major organ inhabited by gut
bacteria. At birth, the small intestinal mucosa is lined by enterocytes ready for rapid uptake
of colostral macromolecules (open gut). These enterocytes, so called fetal type enterocytes,
are equipped with a system of vesicles and cisterns (apical canalicular system, ACS) which
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form large size mobile vacuoles in the upper part of the cell enabling the transfer of intact
colostral  molecules  into  the  blood (Baintner  2002).  Approximately  two days  after  birth,
following substantial intake of colostral bioactive substances, the permeability of the gut
epithelium is dramatically reduced to macromolecules due to the rapid replacement of fetal
type enterocytes by adult type enterocytes, a phenomenon known as gut closure; the cell
replacement is  made by a  receptor-mediated apoptosis  involving TGF-β1 and TNF-α as
mediators  (Godlewski  et  al.,  2005,  Strzałkowski  et  al.,  2007).  Consequently,  adult  type
enterocytes do not contain ACS and large vacuoles. Interestingly, in the gut of neonatal pigs
the cells undergoing apoptosis, which is followed by unzipping-zipping events markedly
disrupting epithelial cell continuity, are located on the entire length of the villi (Godlewski
et al., 2005; see also Fig. 1). In contrast, in adult animals the apoptotic cells are observed only
on the villi top, forming a so called extrusion zone. Therefore, in neonates there is a much
wider absorptive surface that is potentially subject to environmental stimuli as compared to
adults. Though, one population of fetal type enterocytes disappears within the first few days
after birth, there is still another population of fetal type enterocytes existing in the lower
small  intestine,  in  piglets  observed  until  approximately  three  weeks  after  birth.  These
enterocytes  are  important  for  the  intracellular  digestion  of  nutrients  by  lysosomal  en‐
zymes, and form digestive vacuoles as a result of non-selective macromolecule uptake. Their
massive loss in piglets is  observed 2-3 weeks after birth.  Nevertheless the protection by
intestinal mucus and colostral biologically active peptides and proteins, extensive apopto‐
sis  and  unzipping-zipping  of  a  great  number  of  epithelial  cells  at  the  same  time  may
potentially  open  epithelial  gates  for  any  xenobiotics  and  harmful  bacteria,  and  thereby
facilitate their transfer into blood circulation.
Studies of preterm piglets and intrauterine growth retarded (IUGR) piglets demonstrated that
the gut barrier in both groups of animals is open for a longer time than in full-term-appropriate
weight piglets. Namely, the lower part of the small intestine of 28 day-old IUGR piglets still
contained fetal type enterocytes expressing digestive vacuoles indicating marked delay in gut
mucosa development (Mickiewicz et al. 2012 JPP). The gut epithelium continuity in IUGR and
preterm neonates is not as finely controlled as in control rats; abnormalities of the gut epithe‐
lium may facilitate exposure of the gut and in turn the whole organism to external factors or
xenobiotics. It is possible that gut permeability is altered in critically ill children and predispose
them to bacterial translocation via a mechanism that creates a hostile environment in the gut
and alters the gut microbiome favoring the growth of pathogens that promote bacterial
translocation (Papoff et al., 2012).
Recent studies indicate that the vagus nerve is involved in immunomodulation as suggested
by its ability to attenuate the production of proinflammatory cytokines in experimental models
of inflammation (de Jonge and Ullola, 2007). Furthermore, functional development of the
vagus nerve occurs at two stages with the neuronal population in the dorsal motor nucleus of
the vagus (DMNV) maturing ahead of the sensory neuron population of the vagal sensory
nucleus NTS (Islami et al., 2008). There appears to be an important link between the vagus
nerve and memory recall in infancy suggesting that social learning, modulated by autonomic
nervous system, may be jeopardized in preterm infants (Haley et al., 2010)
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In conclusion, maturation of the autonomic nervous system may be delayed in preterm and
IUGR animals. Furthermore, delayed development of the GIT in preterm and IUGR animals,
including longer gut permeability, facilitates the toxic effect of external factors including
bacterial translocation. Furthermore, the immature gut seemingly fails to stimulate the
development of the vagus nerve. Importantly, there is some evidence pointing to altered gut
permeability (leaky gut) in autism and possibly genetic predisposition to abnormalities in tight
junctions in ASD (White, 2003; de Magistris et al, 2010).
4. Determinants of individual sensitivity of brain-gut axis and gut
microbiome to environmental toxins; intrinsic and extrinsic components
Studies of the human microbiome revealed that even healthy individuals differ remarkably in
the microbes of the gut. The gut microbiome is regulated by both extrinsic and intrinsic factors.
 
 
Figure 1. Packetts of apoptotic cells in the epithelium of neonatal piglets. Massive apoptosis is evidenced by scan‐
ning electron microscope (SEM) image by shortened microvilli, several yet unzipped spaces between cells are present.
(SEM images generously supplied by dr. Tomasz Skrzypek, Catholic University of Lublin, Poland)
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While much of this biodiversity remains unexplained, extrinsic factors such as diet, environ‐
ment, and early microbial exposure, and the intrinsic factors such as host genetics have been
implicated (Human Microbiome Project Consortium, 2012); our own studies (Sulkowski et al.,
2012) suggest that sex may play an important role. Diet-derived carbohydrates that are not
fully digested in the upper gut are metabolized by bacteria in the human large intestine. These
nondigestable carbohydrates influence microbial fermentation and total bacterial number in
the colon. Human milk, unlike milk of other mammalian species, contains high amounts of
oligosaccharides of yet unknown function, but one can speculate that dietary oligosaccharides
may play an important function in the development of the microbiome in human neonates.
Evidence exists that the amount and type of nondigestable carbohydrates influence the species
composition of the intestinal microbiome. Individual variation in the gut microbiome may, in
part reflect differences in dietary intake, but the response of the gut microbiome to dietary
change can also differ among individuals (Flint, 2012)
Furthermore, an outcome of the exposure to infectious microbes or their toxins is also influ‐
enced by both microbial and host genes. Some host genes encode defense mechanisms,
whereas others assist pathogen function. Extensive human diversity in cell lethality dependent
on toxin binding and uptake has been observed (Martchenko et al., 2012). Furthermore, there
is evidence that individuals may evolve their own specific microbiome (Clayton, 2012).
Results of our recent animal studies (Sulkowski et al, 2012; Khan et al, 2012, Xu et al, submitted;
see also Fig. 2) indicate that the sensitivity of the developing CNS to both environmental toxins
and infection, are both sex- and rat strain-dependent. It can be extrapolated that the sensitivity
of the human microbiome is also sex-dependent. Because of this individual variability in host
response it is not surprising that the results of human postmortem studies of ASD brains are
difficult to interpret.
5. Microbiome
The human GIT harbors a large number (1000 to 1150) of bacterial species and is involved in
maintaining homeostasis and well-being. Functions of this microbiome include the regulation
of the mucosal immune system, GIT motility, epithelial barrier regulation, gut secretion,
digestion and metabolism (Grenham et al., 2011). One of the main functions of gut microbes
is to extract nutrients from otherwise indigestible fibers (Tremaroli and Backhed, 2012). The
microbiome, absent at birth, is gradually colonized by facultative bacteria and anaerobic
bacteria (Grenham et al., 2011).
Several lines of evidence point to both brain-gut axis and gut microbiome abnormalities in
autism which are summarized in Fig 3. Children with ASD frequently present a variety of
gastrointestinal (GI) symptoms, although some claim that the data supporting increased GI
symptomology in autistic children not to be rigorous enough (Erickson et al., 2005). The so-
called “bacterial theory” of autism proposes the GIT symptoms are associated with changes
in microbial composition and that these changes could be involved in the pathogenesis or
progression of several childhood diseases including autism (Somma et al., 2010).
Gut Microbiome and Brain-Gut Axis in Autism — Aberrant Development of Gut-Brain Communication…
http://dx.doi.org/10.5772/55425
67
It has been suggested that an abnormal gut microbiome in some ASD children may be due to
certain antimicrobial drugs that play a key role in modifying the intestinal bacterial flora and
selecting potentially harmful bacteria normally kept at bay by the innate intestinal flora. And
so, both Clostridia (Finegold, 2011b) and Desulfovibrio (Finegold, 2011a) have been implicated
in autistic pathology. Clostridia form spores and the spores could likely survive antibiotic
treatment and subsequently flourish. Desulfovibrio is an anaerobic bacillus that does not
produce spores and is resistant to some antibiotics such as cephalosporins used in treatment
of common childhood diseases such as ear infections (Finegold, 2011a). An increase in
Bacteroides, a decrease in Firmicutes with an overall increase in biodiversity has been observed
in IBD, celiac disease and autism (Iebba et al., 2011). An increase in Clostridium histolyticum, a
recognized toxin producer with systemic effects, has been observed in fecal samples of ASD
children (Parracho et al., 2005). A strong correlation of gastrointestinal symptoms with autism,
and a decrease in Bifidobacteria and increase in Lactobacilli, was observed in fecal samples of
ASD children (Adams et al., 2011). An association between high levels of intestinal, mucoepi‐
thelial-associated Sutterella species and GI disturbances has been detected in intestinal biopsy
samples in children with autism (Williams et al., 2012). This latter study may provide the most
accurate picture of the gut microbiome as the data were derived directly from the gut.
A response to oral treatment with vancomycin, not absorbed from the GI tract, in autism
suggests the importance of gut flora in a disease (Finegold, 2011a). Evidence suggests that
ASD may be associated with altered innate immune response; thus children with GI problems
may reflect inflammation as a reaction to an endotoxin produced by gut bacteria (Jyonou‐
chi et al, 2002).
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Figure 2. The effect of LPS exposure on cerebellar gene expression. Gene expression was measured by quantita‐
tive RT-PCR in cerebellar tissue of rat pups exposed perinatally to LPS (200μg/kg BW) and was normalized to cyclophi‐
lin A. Panel A: males, Panel B: females. Data are presented as relative gene expression (mean±S.E.M.; *, p< 0.05; +, p<
0.1; Xu et al., submitted).
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Our most recent studies suggest altered expression of ghrelin, the activating enzyme (ghrelin
O-acyltransferase, GOAT) and the receptor in several brain areas of autistic children (Sajdel-
Sulkowska, unpublished observation). A decrease in ghrelin mRNA has been also observed
in the temporal gyrus of Alzheimer patients (Gahete et al., 2010) suggesting ghrelin may
contribute to the severity of AD pathology. Since we have measured the levels of ghrelin
mRNA, it can be assumed that the changes observed were due to the altered levels of brain
ghrelin.
The majority of circulating ghrelin is synthesized by gastric mucosa X/A-like cells in response
to negative energy status. These cells are not typical endocrine cells since the oxyntic mucosa
cells produce HCl in the stomach lumen and ghrelin as a hormone. Ghrelin is the most potent
orexigenic peptide, and plays an important role in glucose metabolism and also in GIT
cytoprotection. In addition to its ability to stimulate appetite, ghrelin stimulates the release of
growth hormone release via the growth secretagogue, GHS-R1a receptor. Ghrelin O-acyl‐
transferase, GOAT, is the enzyme that activates ghrelin. The ghrelin/GHS-R/GOAT system
may play an important role in metabolic disorders in children (Lim and Korbonits, 2012). In
addition to the ghrelin of GIT origin, and the hypothalamus being the main source of brain
ghrelin, ghrelin has been detected in the midbrain, hindbrain, hippocampus, spinal cord and
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Figure 3. Altered gut microbiome and the brain gut axis in autism. S-R-CTR, social reward center; F-R CTR, food reward
center.
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several organs outside the brain. While the systemic endogenous ghrelin exerts a tonic
stimulating effect on hypothalamic CRH (Rucinski et al., 2012), its function in the brain includes
the modulation of membrane excitability, control of neurotransmitter release, neuronal gene
expression, and neuronal survival and proliferation (Ferrini et al., 2009).
It has been reported that ghrelin of GIT origin interacts with bacterial toxins (Tiaka et al.,
2011) and exerts a protective role in experimental colitis; is it possible that the ghrelin of brain
origin plays a protective role as well? If so, changes in the level of brain-derived ghrelin could
be detrimental to the developing brain.
6. Existing and emerging therapeutic strategies in autism targeting the gut-
brain axis and gut microbiome: Role of individual microbes and dietary
amino acids in maintaining gut-brain homeostasis
Existing therapies targeting the gut microbiome include diet, antibiotics, and probiotics.
Dietary restriction, including the removal of dairy casein-containing products, wheat and
gluten sources, sugar, chocolate, preservatives, and food coloring have all been found to be
therapeutic in autism. Interestingly, dairy casein-containing products stimulate ghrelin (a
hunger hormone) and reduce CCK (a satiety agent) production in the periphery and in the
brain. Gastrointestinal problems in autism appear to respond to antimicrobial agents. Treat‐
ments targeting Candida, and probiotics have been used to reduce disbiosis and control gut
permeability (Kidd, 2002). Other strategies include the removal of heavy metals (including
mercury) by chelation and sulfur-sulphydryl repletion. Supplementation with dimethylgly‐
cine, vitamin B6, magnesium, vitamin B3, C, folic acid, calcium and zinc, cod liver, digestive
enzymes, all appear to be beneficial in a number of autistic children (Kidd, 2002). Immune
therapies, including pentoxifyllin, immunoglobulin, transfer factors and colostrums appear to
work in a limited number of cases,
The initial promising use of secretin, a triggering factor for digestion, in the treatment of autism
has been more recently disclaimed. In multiple randomized controlled trials secretin offered
no significant benefit (Krishnaswami et al., 2011; Williams et al., 2012).
Abnormalities in the primary pathway for carbohydrate digestion and transporters, involving
disaccharidases and hexose transporters, have been reported and found to be accompanied by
dysbiosis as evidenced by a decrease in Bactoroidetes and an increase in the ratio of Firmicutes
to Bacteroidetes (Williams et al., 2011). These abnormalities respond to probiotic and dietary
responses (Williams et al., 2011). Probiotic therapy appears to influence microbiome compo‐
sition, intestinal barrier function and mucosal immune responses (Critchfield et al., 2011).
There is evidence to support alterations of fecal microbiome in autism, and in the majority of
cases treatment with vancomycin, an antibiotic that targets gram positive anaerobes and is
minimally absorbed by the gut, can improve symptoms (Sandler et al., 2000).
Recently therapies targeting the gut microbiome are emerging as a viable strategy in the
treatment of CNS disorders (Forsythe et al., 2010). Preclinical studies of selected probiotics in
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healthy volunteers (Messaoudi et al., 2011) provided encouraging results for further studies
exploring the concept of microbial targeting of the GIT under pathological conditions includ‐
ing autism. Individually tailored probiotic formulations, enriched in specific strains of gut
bacteria, could one day be used in treatments of ASD even as an adjuvant to other treatments.
7. Possible connection of gut microbiome and behavior; microbiome and
behavioral abnormalities in ASD
The intestinal microbiome participates in the development of the HPA axis (Sudo et al., 2004)
and is critical to the development of appropriate stress response later in life, which occurs
during a narrow, critical developmental window. This process involves both the regulation of
the levels of brain derived neurotrophic factor (BDNF) and NMDA receptors (Sudo et al.,
2004). The microbiome also plays an important role in anxiety-like behavior (Messaoudi et al.,
2011), depressive behaviors (Neufield et al., 2011; Messaoudi et al., 2011), but the effects are
diminished in vagatomized animals, suggesting either the direct communication between the
bacteria and the brain (Bravo et al., 2011) or through the brain-gut axis. The latter possibility
is an indirect action of bacteria on an afferent vagal pathway via gut immune, endocrine and
enteric nervous system (ENS) controlling mechanisms.
Animal studies have also shown that stress can change the composition of the microbiome,
where the changes are associated with increased vulnerability to inflammatory stimuli in the
GIT (Gareau et al., 2006); here the microbiome plays an important role in memory dysfunction
(Gareau et al., 2011). Stress is known to inhibit gut contraction, one of the crucial defense
strategies against bacterial colonization of gut mucosa. Early psychological trauma of maternal
separation resulted in persistent mucosal barrier dysfunction in neonatal rats, including host
defense to luminal bacteria, by mechanisms involving peripheral CRH receptors (Gareau et
al., 2006).
Oral antibiotics disrupt the microbiome and favor environment for opportunistic bacteria.
Clostridium tetani, an anaerobic bacillus produces a potent neurotoxin, tetanus neurotoxin
(TeNT) that is transported by the vagus nerve from the GI to the CNS. In the brain TeNT
disrupts the release of neurotransmitters by the proteolytic cleavage of synaptobrevin, a
synaptic vesicle membrane protein. This inhibition may be related to a variety of behavioral
deficits characteristic of autism. Some children with autism treated with anti-clostridia
antibiotics have shown a reduction in stereotyped behavior (Bolte, 1998).
8. The role of the reward system in gut-brain communication, the
interaction between food-reward and social-reward systems; altered gut-
microbiome regulation of the reward loop in autism?
Autism is characterized by both severe deficits in social interaction and communication and
significant eating difficulties with a highly restricted range of food choices (Williams et al.,
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2000). It seems logical to hypothesize that altered composition of the gut microbiome under a
“leaky gut” condition in autism interferes with the normal activity of the reward circuitry
including both social and feeding behavior, as illustrated in Fig. 3. In support of this hypothesis
are the neuroimaging, electrophysiological and neurochemical data suggesting a disruption
in reward seeking tendencies in ASD, and especially in social contexts (Kohls et al., 2012). It
has been proposed that this disruption is caused by abnormalities of the dopaminergic-
oxytocinergic “wanting circuitry” that includes the ventral striatum, amygdale, and the
ventromedial prefrontal cortex (Kohls et al., 2012). Indeed, Individuals with ASD are charac‐
terized by low responsiveness to social rewards (Dawson et al., 2005; Schultz, 2005; Neuhaus
et al, 2010). Recent studies of the left amygdala and orbito-frontal cortex, which are the main
components of the social brain, showed neuronal dysfunctions in these structures in autism
(Mori et al, 2012). Furthermore, brain levels of serotonin, the “happy hormone” are regulated
by gut bacteria as evidenced by studies involving germ-free animals (Clarke et al., 2012).
Abnormalities in blood serotonin levels are consistently altered in a subset of children with
ASD.
It is also possible that the abnormalities in vagus nerve functions may further contribute to
social deficits in autism (Goetz et al., 2010). ). It is thus of interest (Ito and Craig, 2008) that
there is a possibility that the vicerosensory information is sent via the vagus nerve directly to
the reward centers. The vagus nerve is involved in our emotional responses and in feelings of
compassion as shown in vagal stimulation, suggesting that the social bond is related to the
gut-brain axis (Goetz et al., 2010). Studies utilizing single-photon emission tomography (SPET)
provide evidence for the limbic system-vagal nerve connection (Barnes et al., 2003). Vagotomy
was for decades a method of choice in treating a number of gastric diseases in adults; it would
be of interest to address it in context of autistic pathology.
Furthermore, the intestinal microbiome regulates the HPA during both development and
adulthood (Sudo et al., 2004) and plays an important role in the stress response. Activation of
the HPA axis involves the release of endogenous opioids which are components of the brain
reward system (Adam et al., 2007).
In humans, sensory factors, such as taste and smell, have an important role in reward-related
feeding (Rolls, 2011); gustatory, olfactory, visual and somatosensory aspects of food are
regulated by the orbitofrontal cortex. Environmental cues, as well as cognitive, reward, and
emotional factors play an important role in food intake which may override the homeostatic
requirements (Berthoud, 2006). Environmental cues regulate endocannabinoid and opioid
systems which play an important role in reward-related feeding and have wide receptor
distributions within the CNS (Cota et al., 2006). Hypothalamic endocannabinoids increase food
intake through a leptin-regulated mechanism. The nucleus accumbens is a key limbic pathway
and may be implicated in regulation of hedonistic and homeostatic feeding (Berthoud, 2006).
Dopamine appears to be associated with reward-related food intake and with behaviors
required to maintain feeding essential for survival (Di Marzo et al., 2001).
The neural circuit mediating reward-related behavior is a complex network that includes the
midbrain, substantia nigra, the amygdala, the ventral striatum, the ventromedial prefrontal
Recent Advances in Autism Spectrum Disorders - Volume I72
cortex and ventral anterior cingulated cortex with the central relay located in ventral striatum
(Kohls et al., 2012).
It is interesting, that the ventral striatum is associated with both social-reward and food-reward
circuitry (Adam et al., 2007). Although it is generally assumed that the two centers are separate,
the observation of altered sucrose preference and positive correlation with ventral striatum
dopamine levels under conditions of social isolation stress in perinatal rats lends support to
the speculation of inter-connectivity of the two centers (Brenes and Fornaguera, 2008).
9. Conclusions
The “leaky gut” during development may be potentially more vulnerable to environmental
insults than the normally developing GIT. Consequently, alterations in the gut microbiome
may play an important role in autistic pathology. Evidence is growing that points to an early
developmental abnormality in establishing GIT and innate microbial milieu. The gut micro‐
biome, regulated by both intrinsic and extrinsic factors, may be further jeopardized by
recurrent infections and/or recurrent use of antibiotics. A developmentally abnormal gut
microbiome may in turn affect both the gut-brain axis and brain development and contribute
to the etiology of ASD. Abnormalities in the gut-brain axis may further lead to the aberrant
development of both the social and the food reward system(s) in autism. Future studies
targeting the gut-brain/brain-gut axis in autism and the gut microbiome are warranted, but
must take into consideration individual variation in gut microbiomes and intrinsic and
extrinsic sensitivities and sex. Results of these studies will likely contribute to our under‐
standing of ASD and advance new and viable therapies.
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